The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| EQT CORP | COM | 26884L109 | 4,812 | 150,800 | SH | SOLE | 1 | 0 | 0 | |||
| HOVNANIAN ENTERPRISES-A | COM | 442487401 | 263 | 3,872 | SH | SOLE | 1 | 0 | 0 | |||
| ISHARES MSCI SINGAPORE ETF | COM | 46434G780 | 270 | 13,600 | SH | SOLE | 1 | 0 | 0 | |||
| META PLATFORMS INC-CLASS A | COM | 30303M102 | 2,244 | 10,589 | SH | SOLE | 1 | 0 | 0 | |||
| NEAR INTELLIGENCE INC | COM | 639494111 | 1 | 10,000 | SH | SOLE | 1 | 0 | 0 | |||
| OMNIAB INC | COM | 68218J103 | 1,312 | 356,592 | SH | SOLE | 1 | 0 | 0 | |||
| OVID THERAPEUTICS INC | COM | 690469101 | 3,516 | 1,380,346 | SH | SOLE | 1 | 0 | 0 | |||
| RANGE RESOURCES CORP | COM | 75281A109 | 1,584 | 59,823 | SH | SOLE | 1 | 0 | 0 | |||
| XENON PHARMACEUTICALS INC | COM | 98420N105 | 1,208 | 33,756 | SH | SOLE | 1 | 0 | 0 | |||
| XOMA CORP | COM | 98419J206 | 2,543 | 120,465 | SH | SOLE | 1 | 0 | 0 | |||
| YANDEX NV-A | COM | N97284108 | 337 | 17,811 | SH | SOLE | 1 | 0 | 0 | |||
| BELLUS HEALTH INC | COM | 07987C204 | 905 | 125,731 | SH | SOLE | 1 | 0 | 0 | |||
| MEI PHARMA INC COM STK | COM | 55279B202 | 244 | 1,064,995 | SH | SOLE | 1 | 0 | 0 | |||
| REGENERON PHARMACEUTICALS | COM | 75886F107 | 205 | 250 | SH | SOLE | 1 | 0 | 0 | |||